XML 21 R11.htm IDEA: XBRL DOCUMENT
v3.20.2

Revenue Recognition and Collaborative Arrangements | 6 Months Ended
--- | ---
Jun. 30, 2020
Revenue Recognition and Collaborative Arrangements |
Revenue Recognition and Collaborative Arrangements | 3. Revenue Recognition and Collaborative Arrangements Net Revenue from Collaborative Arrangements Net revenue recognized under our GSK Agreements was as follows: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended June 30, | ​ | Six Months Ended June 30,
(In thousands) |  | 2020 |  | 2019 |  | 2020 |  | 2019
Royalties from a related party - RELVAR/BREO | ​ | $ | 45,570 | ​ | $ | 47,086 | ​ | $ | 101,719 | ​ | $ | 89,826
Royalties from a related party - ANORO | ​ | ​ | 11,199 | ​ | ​ | 10,635 | ​ | ​ | 21,049 | ​ | ​ | 19,205
Royalties from a related party - TRELEGY | ​ | ​ | 15,633 | ​ | ​ | 9,842 | ​ | ​ | 31,768 | ​ | ​ | 17,171
Total royalties from a related party | ​ | ​ | 72,402 | ​ | ​ | 67,563 | ​ | ​ | 154,536 | ​ | ​ | 126,202
Less: amortization of capitalized fees paid to a related party | ​ |  | (3,456) | ​ |  | (3,456) | ​ |  | (6,912) | ​ |  | (6,912)
Royalty revenue | ​ | ​ | 68,946 | ​ | ​ | 64,107 | ​ | ​ | 147,624 | ​ | ​ | 119,290
Strategic alliance - MABA program | ​ | ​ | 10,000 | ​ | ​ | — | ​ | ​ | 10,000 | ​ | ​ | —
Total net revenue from GSK | ​ | $ | 78,946 | ​ | $ | 64,107 | ​ | $ | 157,624 | ​ | $ | 119,290
​ During the three months ended June 30, 2020, we recognized $10.0 million in revenue in connection with the termination of the Bifunctional Muscarinic Antagonist-Beta2 Agonist (“MABA”) program under the Strategic Alliance Agreement with GSK.

X
- References No definition available. + Details
Name: | us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -URI http://asc.fasb.org/topic&trid=49130388 + Details
Name: | us-gaap_RevenueFromContractWithCustomerTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration